Skip to main content

Want a detailed portfolio tracker?

LAVA Therapeutics (LVTX) P/E (2024 - 2025)

LAVA Therapeutics (LVTX) P/E from Apr 1, 2024 to Dec 5, 2025. The TTM LAVA Therapeutics (LVTX) P/E is -1.97. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of LAVA Therapeutics (LVTX)

YearP/EChange
2025-1.97+94.88%
2024-1.01N/A

Comparison LAVA Therapeutics (LVTX) P/E with competitors

LAVA Therapeutics (LVTX) P/E is -1.97.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.10-105.18%
ENLVEnlivex Therapeutics Ltd0.15-107.61%
FGENFibroGen Inc0.24-112.16%
TRAWTraws Pharma Inc0.47-123.95%
FBIOFortress Biotech Inc0.71-135.77%
CHRSCoherus Biosciences Inc0.98-149.56%
ORMPOramed Pharmaceuticals Inc1.47-174.65%
AGENAgenus Inc2.05-203.78%
VIVSVivoSim Labs Inc2.54-228.47%
INVAInnoviva Inc3.19-261.54%
CRMDCorMedix Inc3.65-284.70%
ABEOAbeona Therapeutics Inc4.20-313.04%
VXRTVaxart Inc4.26-315.91%
CVACCureVac N.V.4.45-325.23%
SRPTSarepta Therapeutics Inc4.62-334.28%
GLPGGalapagos NV4.86-346.17%
RIGLRigel Pharmaceuticals4.92-349.24%
ZVRAZevra Therapeutics Inc4.97-352.00%
ABUSArbutus Biopharma Corp5.69-388.47%
CGENCompugen Ltd7.38-474.10%
AUPHAurinia Pharmaceuticals Inc9.25-568.72%
ACADAcadia Pharmaceuticals Inc9.59-585.77%
OMEROmeros Corporation9.88-600.74%
PLXProtalix BioTherapeutics Inc9.91-602.04%
SPROSpero Therapeutics Inc10.73-643.87%
ADMAAdma Biologics Inc11.33-674.06%
SVASinovac Biotech Ltd11.44-679.40%
TBPHTheravance Biopharma Inc11.78-696.66%
HRMYHarmony Biosciences Holdings Inc12.18-717.12%
TGTXTG Therapeutics Inc13.18-767.73%
INCYIncyte Corp13.38-777.99%
SABSSAB Biotherapeutics Inc14.06-812.23%
XOMAXOMA Corp14.95-857.19%
REGNRegeneron Pharmaceuticals Inc14.98-858.97%
PBYIPuma Biotechnology Inc15.05-862.52%
EXELExelixis Inc15.79-900.24%
NAGENiagen Bioscience Inc16.35-928.62%
CPRXCatalyst Pharmaceuticals Inc17.34-978.76%
MDXGMimedx Group Inc17.38-980.32%
ARGXArgen X SE23.07-1268.91%
HALOHalozyme Therapeutics Inc23.20-1275.45%
XOMAOXOMA Corp25.34-1384.08%
VRTXVertex Pharmaceuticals Inc25.66-1399.84%
XOMAPXOMA Corp25.67-1400.57%
CTMXCytomX Therapeutics Inc25.70-1401.97%
ASNDAscendis Pharma A/S26.35-1435.22%
RPRXRoyalty Pharma plc - Class A27.50-1493.05%
SLNOSoleno Therapeutics Inc29.02-1570.05%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1629.39%
BMRNBiomarin Pharmaceutical Inc37.51-2000.29%
APLSApellis Pharmaceuticals Inc39.02-2077.00%
KRYSKrystal Biotech Inc39.70-2111.26%
GMABGenmab40.20-2136.90%
ONCBeiGene Ltd67.03-3495.90%
TECHBio-Techne Corp68.59-3575.35%
VCELVericel Corp80.63-4185.06%
PHARPharming Group N.V.87.74-4545.33%
ALNYAlnylam Pharmaceuticals Inc124.93-6429.73%
TLXTelix Pharmaceuticals Ltd139.89-7187.52%
CORTCorcept Therapeutics Inc158.39-8124.75%